Such possibilities, to be studied in future work, not only point to a new understanding of the role of MCT4 in cancer, but also have potential for non-invasive detection of MCT4 in cancer patients for diagnostic- or treatment-monitoring purposes. Here, SLC16A3 is linked to cancer.